Claudia Guerrieri
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Pembrolizumab-Sacituzumab Govitecan Combination to Treat High-risk, Localized Bladder Cancer (NCT05535218) | Claudia Guerrieri | 2023-09-20 |
Track Claudia Guerrieri automatically
Every clearance here is in the API, with alerts when new ones post.